A Multicenter Randomized Trial of Fludarabine and Mitoxantrone (FM) Plus Rituximab Versus CHOP Plus Rituximab as First-Line Treatment in Patients with Follicular Lymphoma (FL)

Reviewer: Ryan Smith, MD
OncoLink
Ultima Vez Modificado: 9 de diciembre del 2002

Translation for this article does not exist